Median age (median, IQR) | 65 | (57–71) |
---|---|---|
Gender (n, %) | ||
Male | 68 | 59% |
Female | 48 | 41% |
Overall survival in months (median, IQR) | 23.6 | (11.3–34.1) |
Tumour size in cm, pathology (median, IQR) | 2.5 | (1.8–3.5) |
Tumour size in cm, on MRI (median, IQR) | 2.1 | (1.7–3.3) |
Hypoxia staining score (n lesions, %) | ||
Low | 67 | 47% |
High | 75 | 53% |
Hypoxia staining index score (n resections, %) | ||
Score = 0 | 20 | 14% |
Score = 1 | 23 | 16% |
Score = 2 | 24 | 17% |
Score = 3 | - | - |
Score = 4 | 55 | 39% |
Score = 5 | - | - |
Score = 6 | 20 | 14% |
Location of tumours (n lesions, %) | ||
S1 | 1 | 1% |
S2 | 21 | 11% |
S3 | 29 | 15% |
S4 | 23 | 12% |
S5 | 25 | 13% |
S6 | 34 | 17% |
S7 | 34 | 17% |
S8 | 33 | 17% |
Availability of sequence (n resections, %) | ||
T2W TE75 | 92 | 79% |
T2W TE300 | 85 | 73% |
b0 | 100 | 86% |
b10 | 113 | 97% |
b200 | 99 | 85% |
b800 | 116 | 100% |
ADC | 110 | 95% |